RVTY * Stock Overview
Provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Revvity, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2,420.00 |
| 52 Week High | US$2,595.00 |
| 52 Week Low | US$2,343.00 |
| Beta | 1.09 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -18.16% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 35.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| RVTY * | MX Life Sciences | MX Market | |
|---|---|---|---|
| 7D | 0% | 0% | 0% |
| 1Y | -18.2% | 0% | 0% |
Return vs Industry: RVTY * underperformed the MX Life Sciences industry which returned -14.6% over the past year.
Return vs Market: RVTY * underperformed the MX Market which returned 3.7% over the past year.
Price Volatility
| RVTY * volatility | |
|---|---|
| RVTY * Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 0% |
| Market Average Movement | 0% |
| 10% most volatile stocks in MX Market | 0% |
| 10% least volatile stocks in MX Market | 0% |
Stable Share Price: RVTY * has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RVTY *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1937 | 16,700 | Prahlad Singh | www.revvity.com |
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services.
Revvity, Inc. Fundamentals Summary
| RVTY * fundamental statistics | |
|---|---|
| Market cap | Mex$278.82b |
| Earnings (TTM) | Mex$6.00b |
| Revenue (TTM) | Mex$51.35b |
46.4x
P/E Ratio5.4x
P/S RatioIs RVTY * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RVTY * income statement (TTM) | |
|---|---|
| Revenue | US$3.02b |
| Cost of Revenue | US$1.21b |
| Gross Profit | US$1.81b |
| Other Expenses | US$1.46b |
| Earnings | US$353.45m |
Last Reported Earnings
Apr 02, 2023
Next Earnings Date
Aug 01, 2023
| Earnings per share (EPS) | 2.82 |
| Gross Margin | 59.86% |
| Net Profit Margin | 11.69% |
| Debt/Equity Ratio | 54.3% |
How did RVTY * perform over the long term?
See historical performance and comparison